0000947871-17-000718.txt : 20170915
0000947871-17-000718.hdr.sgml : 20170915
20170915114452
ACCESSION NUMBER: 0000947871-17-000718
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170915
FILED AS OF DATE: 20170915
DATE AS OF CHANGE: 20170915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glick Michael B
CENTRAL INDEX KEY: 0001549889
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35337
FILM NUMBER: 171087354
MAIL ADDRESS:
STREET 1: C/O WEBMD HEALTH CORP.
STREET 2: 111 EIGHTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WebMD Health Corp.
CENTRAL INDEX KEY: 0001326583
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 202783228
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 HUDSON STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 212-624-3700
MAIL ADDRESS:
STREET 1: 395 HUDSON STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: WebMD Health Holdings, Inc.
DATE OF NAME CHANGE: 20050510
4
1
ss59045_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-09-15
1
0001326583
WebMD Health Corp.
WBMD
0001549889
Glick Michael B
C/O WEBMD HEALTH CORP.,
395 HUDSON STREET
NEW YORK
NY
10014
0
1
0
0
Exec VP and Co-General Counsel
Common Stock
2017-09-15
4
U
0
9814
66.50
D
28000
D
Common Stock
2017-09-15
4
D
0
28000
66.50
D
0
D
Common Stock
2017-09-15
4
U
0
383
66.50
D
0
I
By 401(k) Plan
Stock Option (right to buy)
46.81
2017-09-15
4
D
0
25000
D
2020-06-28
Common Stock
25000
0
D
Stock Option (right to buy)
38.65
2017-09-15
4
D
0
75000
D
2023-12-18
Common Stock
75000
0
D
Stock Option (right to buy)
42.99
2017-09-15
4
D
0
42500
D
2025-03-25
Common Stock
42500
0
D
Stock Option (right to buy)
49.00
2017-09-15
4
D
0
75000
D
2026-11-02
Common Stock
75000
0
D
Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement").
On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each restricted share that was outstanding and unvested immediately prior to the completion of the Merger was converted into the right of the holder to receive an amount in cash equal to $66.50, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such restricted share (or earlier if subject to acceleration in accordance with its terms).
Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).
All of the shares underlying the options expiring on June 28, 2020 are vested. For the options expiring on December 18, 2023, 25,000 underlying shares are unvested. For the options expiring on March 25, 2025, 21,250 underlying shares are unvested. For the options expiring on November 2, 2026, all underlying shares are unvested.
/s/ Lewis H. Leicher, Attorney-in-Fact for Michael B. Glick
2017-09-15